EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Haemophilia care in Asia: Learning from clinical practice in some Asian countries

Pantep Angchaisuksiri iD, Marilou Amurao-Abiera, Sheng-Chien Chou, Pol Chewcharat, Novie Amelia Chozie, Roy Gomez, Tien Sim Leng, Pei-Chin Lin iD, Nguyen Thi Mai, Zulaiha Muda, Tulika Seth iD, Darintr Sosothikul iD und 1 weitere

Haemophilia · 2024-05 · 30 (3) · 609-616

DOI: 10.1111/hae.14998 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Haemophilia, online erschienen am 24.03.2024. Verfasst von Pantep Angchaisuksiri und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Hemophilia A. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Pfizer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The healthcare systems in Asia vary greatly due to the socio‐economic and cultural diversities which impact haemophilia management.

Methods

An advisory board meeting was conducted with experts in haemophilia care from Asia to understand the heterogeneity in clinical practices and care provision in the region.

Findings

The overall prevalence of haemophilia in Asia ranges between 3 and 8.58/100,000 patients. Haemophilia A was more prevalent as compared to haemophilia B with a ratio of around 5:1. There is under‐diagnosis in the region due to lack of diagnosis, registries and/or lack of appropriate facilities in suburban areas. Most patients are referred to the haematologists by their families or primary care physicians, while some are identified during bleeding episodes. Genetic testing faces obstacles like resource constraints, services available at limited centres and unwillingness of patients to participate. Prophylaxis is offered for people with haemophilia (PWH) with a severe bleeding phenotype. Recombinant factors are approved in most countries across the region and are the preferred therapy. The challenges highlighted for not receiving a high standard of care include patients’ reluctance to use an intravenous treatment, poor patient compliance due to frequency of infusions, budget constraints and lack of funding, insurance, availability and accessibility of factor concentrates. Prevalence of neutralizing antibodies ranged from 5% to 20% in the region. Use of immune tolerance induction and bypassing agents to treat inhibitors depends on their cost and availability.

Conclusion

Haemophilia care in Asia has evolved to a great extent. However, some challenges remain for which a strategic approach along with multi‐stakeholder involvement are needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hemophilia AHumansAsiaPrevalenceDelivery of Health CareHemophilia B

Stichwörter der Autor:innen

Asiachallengesfactor IXfactor VIIIhaemophiliahaemophilia Ahaemophilia B

Autor:innen und Institutionen

  • Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
  • Philippine Children's Medical Center, Cancer and Hematology Division (Head), Quezon City, Philippines.
  • Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Medical Affairs Manager Pfizer Thailand, Bangkok, Thailand.
  • Division of Hematology Oncology, Department of Child Health Science, Dr. Cipto Mangunkusumo Hospital/Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.
  • Emerging Asia Cluster Medical Lead - Rare Disease, Pfizer Singapore, Singapore, Singapore.

ORCID-Profile: Pantep Angchaisuksiri, Pei-Chin Lin, Tulika Seth, Darintr Sosothikul

Förderung

  • Pfizer

Zitieren

APA

Angchaisuksiri, P., Amurao-Abiera, M., Chou, S. C., Chewcharat, P., Chozie, N. A., Gomez, R., Leng, T. S., Lin, P. C., Mai, N. T., Muda, Z., Seth, T., Sosothikul, D., & Siu-Ming Wong, R. (2024). Haemophilia care in Asia: Learning from clinical practice in some Asian countries. Haemophilia, 30(3), 609-616. https://doi.org/10.1111/hae.14998

Vancouver

Angchaisuksiri P, Amurao-Abiera M, Chou SC, Chewcharat P, Chozie NA, Gomez R, et al. Haemophilia care in Asia: Learning from clinical practice in some Asian countries. Haemophilia. 2024;30(3):609-616. doi:10.1111/hae.14998

BibTeX
@article{Angchaisuksiri2024,
  author = {Angchaisuksiri, Pantep and Amurao-Abiera, Marilou and Chou, Sheng-Chien and Chewcharat, Pol and Chozie, Novie Amelia and Gomez, Roy and Leng, Tien Sim and Lin, Pei-Chin and Mai, Nguyen Thi and Muda, Zulaiha and Seth, Tulika and Sosothikul, Darintr and Siu-Ming Wong, Raymond},
  title = {Haemophilia care in Asia: Learning from clinical practice in some Asian countries},
  journal = {Haemophilia},
  year = {2024},
  volume = {30},
  number = {3},
  pages = {609--616},
  doi = {10.1111/hae.14998}
}
Kostenlos starten →